0000950103-16-018564.txt : 20161207 0000950103-16-018564.hdr.sgml : 20161207 20161207161242 ACCESSION NUMBER: 0000950103-16-018564 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20161207 DATE AS OF CHANGE: 20161207 EFFECTIVENESS DATE: 20161207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Premier Pharma E LP CENTRAL INDEX KEY: 0001691695 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-275826 FILM NUMBER: 162039213 BUSINESS ADDRESS: STREET 1: C/O MORGAN STANLEY STRATEGIES II LLC STREET 2: 522 FIFTH AVENUE, 13TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 212-296-6000 MAIL ADDRESS: STREET 1: C/O MORGAN STANLEY STRATEGIES II LLC STREET 2: 522 FIFTH AVENUE, 13TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 D 1 primary_doc.xml X0707 D LIVE 0001691695 Premier Pharma E LP 522 FIFTH AVENUE, 13TH FLOOR NEW YORK NY NEW YORK 10036 212-296-6000 DELAWARE Premier Private SPV 3 LP None Limited Partnership true 2015 - Morgan Stanley Strategies II LLC 522 FIFTH AVENUE, 13TH FLOOR NEW YORK NY NEW YORK 10036 Executive Officer General Partner of the Issuer James Bruno c/o Morgan Stanley Smith Barney LLC 522 Fifth Avenue, 13th Floor New York NY NEW YORK 10036 Director Director of the General Partner Jeremy Beal c/o Morgan Stanley Smith Barney LLC 522 Fifth Avenue, 13th Floor New York NY NEW YORK 10036 Director Director of the General Partner Michael Korn c/o Morgan Stanley Smith Barney LLC 522 Fifth Avenue, 13th Floor New York NY NEW YORK 10036 Director Director of the General Partner Pooled Investment Fund Other Investment Fund false Decline to Disclose 06b false true false true false 50000 Indefinite 0 Indefinite false 0 0 0 0 false Premier Pharma E LP /s/ James Bruno James Bruno Director of the General Partner of the Issuer 2016-12-07